Study period | ||||||
---|---|---|---|---|---|---|
Enrollment | Allocation | Baseline Ax | Intervention | Post Ax | Retention Ax | |
Time point | Week 0 | Week 0 | Weeks 1–12 | Week 13 | Week 18 | |
Enrolment: | ||||||
Eligibility screen | × | |||||
Informed consent | × | |||||
Study group allocation | × | |||||
Intervention: | ||||||
Task-oriented exercise | × | |||||
Generalized exercise | × | |||||
Stretching control | × | |||||
Assessments: | ||||||
Baseline variables (See Table 2) | × | |||||
Primary outcome: | ||||||
T25-FWT | × | × | × | |||
Secondary outcome: | ||||||
TA aMT | × | × | × | |||
Tertiary outcomes: | ||||||
Additional clinical measures | × | × | × | |||
Additional TMS measures | × | × | × | |||
Blood marker measures | × | × | × | |||
Fitness measures | × | × | × | |||
Exit surveys | × | × |